A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
Clinical trial NCT05762510 · RECRUITING
Trial details
- NCT number
- NCT05762510
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2028-04-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.